News - Europabio - Page 9

About us
- What we do
- Who we are
Members
- EuropaBio Members
- About Membership
How we work
Activities
News & Events
- News
- Events
Library

Become a member

✕

11/11/2022

The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it?
28/10/2022

Europe’s potential in advanced Biomanufacturing at the centre of EFIB 2022 discussions
24/10/2022

European Biotech Week 2022: Bringing Biotech to Local Communities
20/10/2022

Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation a success across Europe
19/10/2022

#EFIB2022: Industrial biotechnology community comes together in Vilnius next week
11/10/2022

Factsheet – Vision for Europe: Excellence
11/10/2022

Factsheet – Vision for Europe: Investment
11/10/2022

Factsheet – Vision for Europe: Innovation
06/10/2022

EuropaBio celebrates its inaugural Healthcare BioForum
03/10/2022

Vision for Europe: Innovation, Investment, Excellence | Claire Skentelbery, EuropaBio
30/09/2022

Collaboration, expertise, and infrastructure: key ingredients for gene therapy to thrive in Europe
25/09/2022

European Biotech Week 2022 starts today!
21/09/2022

Vision for Europe:Innovation, Investment, Excellence | Yordan Aleksandrov, Pfizer
21/09/2022

Vision for Europe: Innovation, Investment, Excellence | Tineke Van hooland, bio.be/essenscia
21/09/2022

Vision for Europe: Innovation, Investment, Excellence | Thomas Bols, PTC Therapeutics
21/09/2022

EuropaBio sat down with new Member Freget Glaser & Associés, to learn more about investment and growth opportunities for European biotechnology
21/09/2022

Freget Glaser & Associés joins EuropaBio: steering the innovation potential through a secure legal framework
21/09/2022

EuropaBio sat down with new Member Bon Vivant, to learn more about the future of alternative dairy proteins
21/09/2022

Bon Vivant joins EuropaBio: dairy products with a lower impact on human health, animals and planet
21/09/2022

Factsheet – Sustainable Investment and the EU Bioeconomy

1...7 8 9 10 11...22

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members

Staff

Privacy policy

Legal & cookies

Events

Newsroom

Become a member

© 2025 Europabio. All Rights Reserved. Designed by EYAS

Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.